Biocon Market Cap

Biocon has a market cap or net worth of 395.01 billion as of June 6, 2025. Its market cap has increased by 8.63% in one year.

Market Cap

395.01B

Enterprise Value

593.64B

Revenue

152.62B

Ranking

n/a

PE Ratio

39.01

Stock Price

330.05

Market Cap Chart

Since April 7, 2004, Biocon's market cap has increased from 45.41B to 395.01B, an increase of 769.81%. That is a compound annual growth rate of 10.75%.

Market Cap History

Date	Market Cap	% Change
Jun 6, 2025	395.01B	-9.66%
Dec 31, 2024	437.25B	46.69%
Dec 29, 2023	298.08B	-4.59%
Dec 30, 2022	312.41B	-27.97%
Dec 31, 2021	433.73B	-21.37%
Dec 31, 2020	551.59B	58.78%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	3,994.65B
Divi's Laboratories	1,756.87B
Cipla	1,188.77B
Apollo Hospitals Enterprise	985.64B
Mankind Pharma	973.57B
Zydus Lifesciences	937.31B
Aurobindo Pharma	661.36B
Alkem Laboratories	582.10B

Market Cap Rankings